Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eiger BioPharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 40K | Mar 1, 2023 | Direct | ||
LEAP THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 30K | Jan 29, 2024 | Direct | ||
Paratek Pharmaceuticals, Inc. | Director | Common Stock | 0 | $2.20 | Sep 21, 2023 | Direct | |
Paratek Pharmaceuticals, Inc. | Director | Stock option (right to buy) | 0 | Sep 21, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LPTX | LEAP THERAPEUTICS, INC. | Jan 29, 2024 | 1 | $0 | 4 | Jan 31, 2024 | Director |
PRTK | Paratek Pharmaceuticals, Inc. | Sep 21, 2023 | 9 | $0 | 4 | Sep 21, 2023 | Director |
LPTX | LEAP THERAPEUTICS, INC. | Aug 23, 2023 | 1 | $0 | 4 | Aug 25, 2023 | Director |
LPTX | LEAP THERAPEUTICS, INC. | Mar 31, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Director |
EIGR | Eiger BioPharmaceuticals, Inc. | Mar 1, 2023 | 1 | $0 | 4 | Mar 3, 2023 | Director |
PRTK | Paratek Pharmaceuticals, Inc. | Feb 8, 2023 | 1 | $0 | 4 | Feb 9, 2023 | Director |
EIGR | Eiger BioPharmaceuticals, Inc. | Jan 23, 2023 | 1 | $71.6K | 4 | Jan 25, 2023 | Director |
EIGR | Eiger BioPharmaceuticals, Inc. | Dec 22, 2022 | 1 | -$26.3K | 4 | Dec 27, 2022 | Director |
LPTX | LEAP THERAPEUTICS, INC. | Sep 1, 2022 | 1 | $0 | 4 | Sep 2, 2022 | Director |
EIGR | Eiger BioPharmaceuticals, Inc. | Mar 11, 2022 | 2 | $0 | 4 | Mar 11, 2022 | Director |
PRTK | Paratek Pharmaceuticals, Inc. | Feb 16, 2022 | 1 | $0 | 4 | Feb 18, 2022 | Director |
LPTX | LEAP THERAPEUTICS, INC. | Jan 31, 2022 | 1 | $0 | 4 | Feb 2, 2022 | Director |